BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22015232)

  • 1. Effect of cilostazol on the progression of carotid intima-media thickness: a meta-analysis of randomized controlled trials.
    Geng DF; Deng J; Jin DM; Wu W; Wang JF
    Atherosclerosis; 2012 Jan; 220(1):177-83. PubMed ID: 22015232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of alpha-glucosidase inhibitors on the progression of carotid intima-media thickness: a meta-analysis of randomized controlled trials.
    Geng DF; Jin DM; Wu W; Fang C; Wang JF
    Atherosclerosis; 2011 Sep; 218(1):214-9. PubMed ID: 21640349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of folic acid supplementation on the progression of carotid intima-media thickness: a meta-analysis of randomized controlled trials.
    Qin X; Xu M; Zhang Y; Li J; Xu X; Wang X; Xu X; Huo Y
    Atherosclerosis; 2012 Jun; 222(2):307-13. PubMed ID: 22209480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cilostazol reduces the progression of carotid intima-media thickness without increasing the risk of bleeding in patients with acute coronary syndrome during a 2-year follow-up.
    Ahn CM; Hong SJ; Park JH; Kim JS; Lim DS
    Heart Vessels; 2011 Sep; 26(5):502-10. PubMed ID: 21153029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of cilostazol on the progression of carotid atherosclerosis in patients with retinal vascular occlusion.
    Kim SM; Cho KI
    Cardiovasc Ther; 2013 Dec; 31(6):e94-e101. PubMed ID: 24034133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of cilostazol on carotid intima-media thickness progression in patients with symptomatic intracranial atherosclerotic stenosis.
    Kim BJ; Rha JH; Kim SR; Kim DE; Kim HY; Lee JH; Bae HJ; Han MK; Kang DW; Ratanakorn D; Kim JS; Kwon SU
    J Stroke Cerebrovasc Dis; 2014; 23(5):1164-70. PubMed ID: 24315720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The phosphodiesterase inhibitor cilostazol induces regression of carotid atherosclerosis in subjects with type 2 diabetes mellitus: principal results of the Diabetic Atherosclerosis Prevention by Cilostazol (DAPC) study: a randomized trial.
    Katakami N; Kim YS; Kawamori R; Yamasaki Y
    Circulation; 2010 Jun; 121(23):2584-91. PubMed ID: 20516379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of adjunctive cilostazol to dual antiplatelet therapy after stent implantation: an updated meta-analysis of randomized controlled trials.
    Ding XL; Xie C; Jiang B; Gao J; Zhang LL; Zhang H; Zhang JJ; Miao LY
    J Cardiovasc Pharmacol Ther; 2013 May; 18(3):222-8. PubMed ID: 23263383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized control trial comparing the effect of cilostazol and aspirin on changes in carotid intima-medial thickness.
    Hong S; Nam M; Little BB; Paik S; Lee K; Woo J; Kim D; Kang J; Chun M; Park Y
    Heart Vessels; 2019 Nov; 34(11):1758-1768. PubMed ID: 31056733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Cilostazol for Atherosclerosis: A Meta-analysis of Randomized Controlled Trials.
    Wan H; Huang T; Yang P; Wu T; Zhang H; Wu Q
    J Cardiovasc Pharmacol; 2022 Mar; 79(3):390. PubMed ID: 35255053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A meta-analysis of randomized controlled trials appraising the efficacy and safety of cilostazol after coronary artery stent implantation.
    Jang JS; Jin HY; Seo JS; Yang TH; Kim DK; Kim DS; Kim DK; Seol SH; Kim DI; Cho KI; Kim BH; Park YH; Je HG; Jeong YH; Kim WJ; Lee JY; Lee SW
    Cardiology; 2012; 122(3):133-43. PubMed ID: 22832424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of lipid lowering, hypoglycemic, antihypertensive and antiplatelet medications on carotid artery intima-media thickness progression: a network meta-analysis.
    Huang R; Mills K; Romero J; Li Y; Hu Z; Cao Y; Huang H; Xu Y; Jiang L
    Cardiovasc Diabetol; 2019 Jan; 18(1):14. PubMed ID: 30700294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cilostazol on carotid intima-media thickness in type 2 diabetic patients without cardiovascular event.
    Huh JH; Seok H; Lee BW; Kang ES; Lee HC; Cha BS
    Endocrine; 2014 Sep; 47(1):138-45. PubMed ID: 24381128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cilostazol against the progression of carotid IMT in symptomatic ischemic stroke patients.
    Heo SH; Lee JS; Kim BJ; Hwang KJ; Kim JH; Chang DI
    J Neurol; 2013 Jan; 260(1):122-30. PubMed ID: 22820682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cilostazol reduces restenosis after carotid artery stenting.
    Takigawa T; Matsumaru Y; Hayakawa M; Nemoto S; Matsumura A
    J Vasc Surg; 2010 Jan; 51(1):51-6. PubMed ID: 19879096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cilostazol added to aspirin and clopidogrel reduces revascularization without increases in major adverse events in patients with drug-eluting stents: a meta-analysis of randomized controlled trials.
    Sakurai R; Koo BK; Kaneda H; Bonneau HN; Nagai R
    Int J Cardiol; 2013 Sep; 167(5):2250-8. PubMed ID: 22727963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study.
    Angiolillo DJ; Capranzano P; Goto S; Aslam M; Desai B; Charlton RK; Suzuki Y; Box LC; Shoemaker SB; Zenni MM; Guzman LA; Bass TA
    Eur Heart J; 2008 Sep; 29(18):2202-11. PubMed ID: 18567918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term clinical efficacy and safety of adding cilostazol to dual antiplatelet therapy for patients undergoing PCI: a meta-analysis of randomized trials with adjusted indirect comparisons.
    Chen Y; Zhang Y; Tang Y; Huang X; Xie Y
    Curr Med Res Opin; 2014 Jan; 30(1):37-49. PubMed ID: 24083626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triple antiplatelet therapy vs. dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: an evidence-based approach to answering a clinical query.
    Singh I; Shafiq N; Pandhi P; Reddy S; Pattanaik S; Sharma Y; Malhotra S
    Br J Clin Pharmacol; 2009 Jul; 68(1):4-13. PubMed ID: 19659998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet inhibition by adjunctive cilostazol suppresses the frequency of cerebral ischemic lesions after carotid artery stenting in patients with carotid artery stenosis.
    Nakagawa I; Wada T; Park HS; Nishimura F; Yamada S; Nakagawa H; Kichikawa K; Nakase H
    J Vasc Surg; 2014 Mar; 59(3):761-7. PubMed ID: 24239116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.